Main Business：专注于为肿瘤的早期精准诊断和治疗提供具有临床价值的先进技术，产品涵盖三大技术领域：早期肿瘤微创诊疗通道技术、实时无创可视化活检技术、早期肿瘤微创治疗技术。Company Type：Medical Device Supplier
Size：1-49人
Capital：2万RMB
Establishment：2014
Sell：专注于为肿瘤的早期精准诊断和治疗提供具有临床价值的先进技术，产品涵盖三大技术领域：早期肿瘤微创诊疗通道技术、实时无创可视化活检技术、早期肿瘤微创治疗技术。
Jinwei Shida Medical Technology (Suzhou) Co., Ltd., formerly Jinwei Shida Medical Technology (Wuhan) Co., Ltd., was founded on December 3, 2014. It is a national high‑tech enterprise and completed Series B+ financing in 2025. Its registered office is at Rooms 804‑805, Building 1, No.188 Fuchunjiang Road, Suzhou High‑Tech Zone.
The company specializes in R&D, manufacturing and commercialization of innovative medical devices. Centered on confocal endomicroscopy technology, it develops three core‑technology platforms: minimally‑invasive access for early‑stage tumor diagnosis and treatment, real‑time non‑invasive visual biopsy, and minimally‑invasive oncological therapy. It leads several national key science‑and‑technology projects in China..
In 2019, it obtained China’s first and the world’s second registration certificate for probe‑based confocal laser endomicroscopy (pCLE), ending long‑term overseas monopoly. Its self‑developed BIOPSEE® confocal imaging system delivers real‑time in‑vivo cellular‑level images with 1000‑fold magnification for optical biopsy. Its ultra‑miniature probes can be as thin as 1‑2.8 mm and fit standard working channels of endoscopes. Its products are deployed in over 30 Grade‑A hospitals across China for gastroenterology, pulmonology and biliary‑pancreatic departments.
The R&D team consists of talents from Tsinghua University, Huazhong University of Science and Technology, University of Electronic Science and Technology of China and overseas universities covering optical engineering, fiber‑optics, image processing, algorithm development, clinical medicine and medical regulatory compliance. The company has built a fully self‑owned intellectual‑property portfolio. It develops Class‑Ⅰ, Class‑Ⅱ and Class‑Ⅲ medical devices including BIOPSEE series, ultra‑thin biliary endomicroscope, FUSION integrated biliary confocal system and Insight visualization system. Committed to domestic substitution of high‑end medical equipment, it cuts down healthcare costs and provides cellular‑level precision diagnostic solutions for patients globally.